BDSX

Biodesix (BDSX)

Biodesix Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BDSX

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/07/27	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/27	07:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/27	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/27	07:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/27	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/27	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDSX	Biodesix Inc
2023/07/27	05:06	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:BDSX	Biodesix Inc
2023/07/24	19:00	Business Wire	Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023	NASDAQ:BDSX	Biodesix Inc
2023/07/12	23:35	AllPennyStocks.com	Strong Open For This Healthcare Stock	NASDAQ:BDSX	Biodesix Inc
2023/07/12	19:00	Business Wire	Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules	NASDAQ:BDSX	Biodesix Inc
2023/07/07	05:31	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2023/07/06	22:11	Business Wire	Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services	NASDAQ:BDSX	Biodesix Inc
2023/07/04	06:02	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:BDSX	Biodesix Inc
2023/06/27	19:00	Business Wire	Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier	NASDAQ:BDSX	Biodesix Inc
2023/06/01	19:00	Business Wire	Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting	NASDAQ:BDSX	Biodesix Inc
2023/05/31	19:00	Business Wire	Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	07:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/26	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BDSX	Biodesix Inc
2023/05/25	19:00	Business Wire	Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing	NASDAQ:BDSX	Biodesix Inc
2023/05/25	04:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BDSX	Biodesix Inc
2023/05/24	19:00	Business Wire	Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors	NASDAQ:BDSX	Biodesix Inc
2023/05/18	20:00	Business Wire	Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference	NASDAQ:BDSX	Biodesix Inc
2023/05/12	05:13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BDSX	Biodesix Inc